Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Coya Therapeutics

Clinical trials sponsored by Coya Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New drug combo aims to slow ALS in landmark trial Results expected Jan 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1
Sort by
  • New drug combo aims to slow ALS in landmark trial

    Disease control Recruiting now

    This Phase 2 trial is testing an investigational drug called COYA 302 in 120 adults with ALS. The drug combines two immune-modulating agents to reduce inflammation that may damage nerves. Participants will receive either COYA 302 or a placebo for 24 weeks, with an option to conti…

    Phase 2/3 • Sponsor: Coya Therapeutics • Aim: Disease control

    Last updated Aug 08, 2026 00:03 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space